Main Menu

Publications

Publications Highlights View all by category

Types of Publications


Journal Articles

Hussain, K. Kawsar, A. Weir, J. Au, L. Turajlic, S. Larkin, J. Fearfield, L. (2022). Severe cutaneous adverse reaction following COVID‐19 vaccination and immunotherapy: a second hit?. Clinical and experimental dermatology, Vol.47 (1), pp. 149-151.

Shum, B. Larkin, J. Turajlic, S. (2022). Predictive biomarkers for response to immune checkpoint inhibition. Seminars in cancer biology, Vol.79, pp. 4-17.

Siddiqui, M.S. Lai, Z.M. Spain, L. Greener, V. Turajlic, S. Larkin, J. Morganstein, D.L. (2021). Predicting development of ipilimumab-induced hypophysitis: utility of T4 and TSH index but not TSH. Journal of endocrinological investigation, Vol.44 (1), pp. 195-203.  show abstract

Tippu, Z. Au, L. Turajlic, S. (2021). Evolution of Renal Cell Carcinoma. European urology focus, Vol.7 (1), pp. 148-151.

Bailey, C. Black, J.R. Reading, J.L. Litchfield, K. Turajlic, S. McGranahan, N. Jamal-Hanjani, M. Swanton, C. (2021). Tracking Cancer Evolution through the Disease Course. Cancer discovery, Vol.11 (4), pp. 916-932.  show abstract

Litchfield, K. Reading, J.L. Puttick, C. Thakkar, K. Abbosh, C. Bentham, R. Watkins, T.B. Rosenthal, R. Biswas, D. Rowan, A. Lim, E. Al Bakir, M. Turati, V. Guerra-Assunção, J.A. Conde, L. Furness, A.J. Saini, S.K. Hadrup, S.R. Herrero, J. Lee, S.-. Van Loo, P. Enver, T. Larkin, J. Hellmann, M.D. Turajlic, S. Quezada, S.A. McGranahan, N. Swanton, C. (2021). Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition. Cell, Vol.184 (3), pp. 596-614.e14.

Edwards, C.L. Comito, F. Agraso Busto, S. Harland, C. Turajlic, S. Larkin, J. Heelan, K. Fearfield, L. (2021). Cutaneous toxicities in patients with melanoma receiving checkpoint inhibitor therapy: a retrospective review The experience of a single large specialist institution. Clinical and experimental dermatology, Vol.46 (2), pp. 338-341.

Rini, B. Abel, E.J. Albiges, L. Bex, A. Brugarolas, J. Bukowski, R.M. Coleman, J.A. Drake, C.G. Figlin, R.A. Futreal, A. Hammers, H. Powles, T. Rathmell, W.K. Ricketts, C.J. Turajlic, S. Wood, C.G. Leibovich, B.C. (2021). Summary from the Kidney Cancer Association’s Inaugural Think Thank: Coalition for a Cure. Clinical genitourinary cancer, Vol.19 (2), pp. 167-175.

Rzeniewicz, K. Larkin, J. Menzies, A.M. Turajlic, S. (2021). Immunotherapy use outside clinical trial populations: never say never?. Annals of oncology, Vol.32 (7), pp. 866-880.

Zhao, Y. Fu, X. Lopez, J.I. Rowan, A. Au, L. Fendler, A. Hazell, S. Xu, H. Horswell, S. Shepherd, S.T. Spain, L. Byrne, F. Stamp, G. O’Brien, T. Nicol, D. Augustine, M. Chandra, A. Rudman, S. Toncheva, A. Pickering, L. Sahai, E. Larkin, J. Bates, P.A. Swanton, C. Turajlic, S. Challacombe, B. Chowdhury, S. Drake, W. Fernando, A. Fotiadis, N. Furness, A. Hatipoglu, E. Harrison-Phipps, K. Hill, P. Horsfield, C. Marafioti, T. Olsburgh, J. Polson, A. Quezada, S. Varia, M. Verma, H. Litchfield, K. (2021). Selection of metastasis competent subclones in the tumour interior. Nature ecology & evolution, Vol.5 (7), pp. 1033-1045.

Gallegos, L.L. Gilchrist, A. Spain, L. Stanislaw, S. Hill, S.M. Primus, V. Jones, C. Agrawal, S. Tippu, Z. Barhoumi, A. Noel-Storr, G. Alexander, N.R. Turajlic, S. (2021). A protocol for representative sampling of solid tumors to improve the accuracy of sequencing results. Star protocols, Vol.2 (3), pp. 100624-100624.

Mendis, S. Ealing, J. Larkin, J. Turajlic, S. Carr, A. Bronstein, A. Kaski, D. (2021). Isolated imbalance due to bilateral vestibular failure following immune checkpoint inhibitor administration: two cases. European journal of cancer, Vol.156, pp. 187-189.

Buck, M.D. Poirier, E.Z. Cardoso, A. Frederico, B. Canton, J. Barrell, S. Beale, R. Byrne, R. Caidan, S. Crawford, M. Cubitt, L. Gandhi, S. Goldstone, R. Grant, P.R. Gulati, K. Hindmarsh, S. Howell, M. Hubank, M. Instrell, R. Jiang, M. Kassiotis, G. Lu, W.-. MacRae, J.I. Martini, I. Miller, D. Moore, D. Nastouli, E. Nicod, J. Nightingale, L. Olsen, J. Oomatia, A. O'Reilly, N. Rideg, A. Song, O.-. Strange, A. Swanton, C. Turajlic, S. Wu, M. Reis e Sousa, C. (2021). SARS-CoV-2 detection by a clinical diagnostic RT-LAMP assay. Wellcome open research, Vol.6, pp. 9-9.  show abstract

Au, L. Fendler, A. Shepherd, S.T. Rzeniewicz, K. Cerrone, M. Byrne, F. Carlyle, E. Edmonds, K. Del Rosario, L. Shon, J. Haynes, W.A. Ward, B. Shum, B. Gordon, W. Gerard, C.L. Xie, W. Joharatnam-Hogan, N. Young, K. Pickering, L. Furness, A.J. Larkin, J. Harvey, R. Kassiotis, G. Gandhi, S. Crick COVID-19 Consortium, Swanton, C. Fribbens, C. Wilkinson, K.A. Wilkinson, R.J. Lau, D.K. Banerjee, S. Starling, N. Chau, I. CAPTURE Consortium, Turajlic, S. (2021). Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2. Nature medicine, .  show abstract

Fendler, A. Shepherd, S.T. Au, L. Wilkinson, K.A. Wu, M. Byrne, F. Cerrone, M. Schmitt, A.M. Joharatnam-Hogan, N. Shum, B. Tippu, Z. Rzeniewicz, K. Boos, L.A. Harvey, R. Carlyle, E. Edmonds, K. Del Rosario, L. Sarker, S. Lingard, K. Mangwende, M. Holt, L. Ahmod, H. Korteweg, J. Foley, T. Bazin, J. Gordon, W. Barber, T. Emslie-Henry, A. Xie, W. Gerard, C.L. Deng, D. Wall, E.C. Agua-Doce, A. Namjou, S. Caidan, S. Gavrielides, M. MacRae, J. Kelly, G. Peat, K. Kelly, D. Murra, A. Kelly, K. O'Flaherty, M. Dowdie, L. Ash, N. Gronthoud, F. Shea, R.L. Gardner, G. Murray, D. Kinnaird, F. Cui, W. Pascual, J. Rodney, S. Mencel, J. Curtis, O. Stephenson, C. Robinson, A. Oza, B. Farag, S. Leslie, I. Rogiers, A. Iyengar, S. Ethell, M. Messiou, C. Cunningham, D. Chau, I. Starling, N. Turner, N. Welsh, L. van As, N. Jones, R.L. Droney, J. Banerjee, S. Tatham, K.C. O'Brien, M. Harrington, K. Bhide, S. Okines, A. Reid, A. Young, K. Furness, A.J. Pickering, L. Swanton, C. Gandhi, S. Gamblin, S. Bauer, D.L. Kassiotis, G. Kumar, S. Yousaf, N. Jhanji, S. Nicholson, E. Howell, M. Walker, S. Wilkinson, R.J. Larkin, J. Turajlic, S. (2021). Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study. Nature cancer, , pp. ?-? (31).

O'Reilly, A. Hughes, P. Mann, J. Lai, Z. Teh, J.J. Mclean, E. Edmonds, K. Lingard, K. Chauhan, D. Lynch, J. Au, L. Ludlow, A. Pattison, N. Wiseman, T. Turajlic, S. Gore, M. Larkin, J. Husson, O. (2020). An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors. Supportive care in cancer : official journal of the multinational association of supportive care in cancer, Vol.28 (2), pp. 561-570.  show abstract

Watkins, T.B. Lim, E.L. Petkovic, M. Elizalde, S. Birkbak, N.J. Wilson, G.A. Moore, D.A. Grönroos, E. Rowan, A. Dewhurst, S.M. Demeulemeester, J. Dentro, S.C. Horswell, S. Au, L. Haase, K. Escudero, M. Rosenthal, R. Bakir, M.A. Xu, H. Litchfield, K. Lu, W.T. Mourikis, T.P. Dietzen, M. Spain, L. Cresswell, G.D. Biswas, D. Lamy, P. Nordentoft, I. Harbst, K. Castro-Giner, F. Yates, L.R. Caramia, F. Jaulin, F. Vicier, C. Tomlinson, I.P. Brastianos, P.K. Cho, R.J. Bastian, B.C. Dyrskjøt, L. Jönsson, G.B. Savas, P. Loi, S. Campbell, P.J. Andre, F. Luscombe, N.M. Steeghs, N. Tjan-Heijnen, V.C. Szallasi, Z. Turajlic, S. Jamal-Hanjani, M. Van Loo, P. Bakhoum, S.F. Schwarz, R.F. McGranahan, N. Swanton, C. (2020). Pervasive chromosomal instability and karyotype order in tumour evolution. Nature, Vol.587 (7832), pp. 126-132.

Litchfield, K. Stanislaw, S. Spain, L. Gallegos, L.L. Rowan, A. Schnidrig, D. Rosenbaum, H. Harle, A. Au, L. Hill, S.M. Tippu, Z. Thomas, J. Thompson, L. Xu, H. Horswell, S. Barhoumi, A. Jones, C. Leith, K.F. Burgess, D.L. Watkins, T.B. Lim, E. Birkbak, N.J. Lamy, P. Nordentoft, I. Dyrskjøt, L. Pickering, L. Hazell, S. Jamal-Hanjani, M. Larkin, J. Swanton, C. Alexander, N.R. Turajlic, S. Abbosh, C. Shiu, K.-. Bridgewater, J. Hochhauser, D. Forster, M. Lee, S.-. Ahmad, T. Papadatos-Pastos, D. Janes, S. Van Loo, P. Enfield, K. McGranahan, N. Huebner, A. Quezada, S. Beck, S. Parker, P. Walczak, H. Enver, T. Hynds, R. Falzon, M. Proctor, I. Sinclair, R. Lok, C.-. Rhodes, Z. Moore, D. Marafioti, T. Borg, E. Mitchison, M. Khiroya, R. Trevisan, G. Ellery, P. Linch, M. Brandner, S. Hiley, C. Veeriah, S. Razaq, M. Shaw, H. Attard, G. Akther, M.A. Naceur-Lombardelli, C. Manzano, L. Al-Bakir, M. Summan, S. Kanu, N. Ward, S. Asghar, U. Lim, E. Gishen, F. Tookman, A. Stone, P. Stirling, C. Furness, A. Edmonds, K. Hunter, N. Sarker, S. Vaughan, S. Mangwende, M. Pearce, K. Spain, L. Shepherd, S. Yan, H. Shum, B. Carlyle, E. Hazell, S. Fendler, A. Byrne, F. Yousaf, N. Popat, S. Curtis, O. Stamp, G. Toncheva, A. Nye, E. Murra, A. Korteweg, J. Sheikh, N. Josephs, D. Chandra, A. Spicer, J. Mahadeva, U. Green, A. Stewart, R. Iredale, L.-. Mackay, T. Deakin, B. Enting, D. Rudman, S. Ghosh, S. Karapagniotou, L. Pintus, E. Tutt, A. Howlett, S. Michalarea, V. Brenton, J. Caldas, C. Fitzgerald, R. Jimenez-Linan, M. Provenzano, E. Cluroe, A. Stewart, G. Watts, C. Gilbertson, R. McDermott, U. Tavare, S. Beddowes, E. Roxburgh, P. Biankin, A. Chalmers, A. Fraser, S. Oien, K. Kidd, A. Blyth, K. Krebs, M. Blackhall, F. Summers, Y. Dive, C. Marais, R. Gomes, F. Carter, M. Dransfield, J. Le Quesne, J. Fennell, D. Shaw, J. Naidu, B. Baijal, S. Tanchel, B. Langman, G. Robinson, A. Collard, M. Cockcroft, P. Ferris, C. Bancroft, H. Kerr, A. Middleton, G. Webb, J. Kadiri, S. Colloby, P. Olisemeke, B. Wilson, R. Tomlinson, I. Jogai, S. Ottensmeier, C. Harrison, D. Loda, M. Flanagan, A. McKenzie, M. Hackshaw, A. Ledermann, J. Sharp, A. Farrelly, L. Bridger, H. (2020). Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue. Cell reports, Vol.31 (5), pp. 107550-107550.

Powell, N. Ibraheim, H. Raine, T. Speight, R.A. Papa, S. Brain, O. Green, M. Samaan, M.A. Spain, L. Yousaf, N. Hunter, N. Eldridge, L. Pavlidis, P. Irving, P. Hayee, B. Turajlic, S. Larkin, J. Lindsay, J.O. Gore, M. (2020). British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis. The lancet gastroenterology & hepatology, Vol.5 (7), pp. 679-697.

Comito, F. Leslie, I. Boos, L. Furness, A. Pickering, L. Turajlic, S. Larkin, J. (2020). Oligoprogression After Checkpoint Inhibition in Metastatic Melanoma Treated With Locoregional Therapy: A Single-center Retrospective Analysis. Journal of immunotherapy, Vol.43 (8), pp. 250-255.

Litchfield, K. Reading, J.L. Lim, E.L. Xu, H. Liu, P. Al-Bakir, M. Wong, Y.N. Rowan, A. Funt, S.A. Merghoub, T. Perkins, D. Lauss, M. Svane, I.M. Jönsson, G. Herrero, J. Larkin, J. Quezada, S.A. Hellmann, M.D. Turajlic, S. Swanton, C. (2020). Escape from nonsense-mediated decay associates with anti-tumor immunogenicity. Nature communications, Vol.11 (1).  show abstract

Spain, L. Larkin, J. Turajlic, S. (2020). New survival standards for advanced melanoma. British journal of cancer, Vol.122 (9), pp. 1275-1276.  show abstract

Spain, L. Tippu, Z. Larkin, J.M. Carr, A. Turajlic, S. (2020). How we treat neurological toxicity from immune checkpoint inhibitors. Esmo open, Vol.4, pp. e000540-e000540.

Favara, D.M. Spain, L. Au, L. Clark, J. Daniels, E. Diem, S. Chauhan, D. Turajlic, S. Powell, N. Larkin, J.M. Yousaf, N. (2020). Five-year review of corticosteroid duration and complications in the management of immune checkpoint inhibitor-related diarrhoea and colitis in advanced melanoma. Esmo open, Vol.5 (4), pp. e000585-e000585.

Hodzic, E. Shrestha, R. Malikic, S. Collins, C.C. Litchfield, K. Turajlic, S. Sahinalp, S.C. (2020). Identification of conserved evolutionary trajectories in tumors. Bioinform., Vol.36, pp. i427-i435.

Shepherd, S.T. Litchfield, K. Turajlic, S. (2019). Searching for the needle in the haystack: deconvoluting the evolutionary dynamics of residual disease in human glioblastoma. Annals of oncology, Vol.30 (3), pp. 355-357.

Turajlic, S. (2019). Standing on the shoulders of giants. Nature medicine, Vol.25 (3), pp. 357-357.

Turajlic, S. Sottoriva, A. Graham, T. Swanton, C. (2019). Resolving genetic heterogeneity in cancer. Nature reviews. genetics, Vol.20 (7), pp. 404-416.  show abstract

Amaria, R.N. Menzies, A.M. Burton, E.M. Scolyer, R.A. Tetzlaff, M.T. Antdbacka, R. Ariyan, C. Bassett, R. Carter, B. Daud, A. Faries, M. Fecher, L.A. Flaherty, K.T. Gershenwald, J.E. Hamid, O. Hong, A. Kirkwood, J.M. Lo, S. Margolin, K. Messina, J. Postow, M.A. Rizos, H. Ross, M.I. Rozeman, E.A. Saw, R.P. Sondak, V. Sullivan, R.J. Taube, J.M. Thompson, J.F. van de Wiel, B.A. Eggermont, A.M. Davies, M.A. Ascierto, P.A. Spillane, A.J. van Akkooi, A.C. Wargo, J.A. Blank, C.U. Tawbi, H.A. Long, G.V. Andrews, M.C. Berry, D.A. Block, M.S. Boland, G.M. Bollin, K.B. Carlino, M.S. Carvajal, R.D. Cohen, J. Davar, D. Delman, K.A. Dummer, R. Farwell, M.D. Fisher, D.E. Fusi, A. Glitza, I.C. de Gruijl, T.D. Gyorki, D.E. Hauschild, A. Hieken, T.J. Larkin, J. Lawson, D.H. Lebbe, C. Lee, J.E. Lowe, M.C. Luke, J.J. McArthur, G.A. McDermott, D.F. McQuade, J.L. Mitchell, T.C. Petrella, T.M. Prieto, P.A. Puzanov, I. Robert, C. Salama, A.K. Sandhu, S. Schadendorf, D. Shoushtari, A.N. Sosman, J.A. Swetter, S.M. Tanabe, K.K. Turajlic, S. Tyler, D.S. Woodman, S.E. Wright, F.C. Zager, J.S. (2019). Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium. The lancet oncology, Vol.20 (7), pp. e378-e389.

Schnidrig, D. Turajlic, S. Litchfield, K. (2019). Tumour mutational burden: primary versus metastatic tissue creates systematic bias. Immuno-oncology technology, Vol.4, pp. 8-14.

Lim, K.H. Spain, L. Barker, C. Georgiou, A. Walls, G. Gore, M. Turajlic, S. Board, R. Larkin, J.M. Lorigan, P. (2018). Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma. Esmo open, Vol.3 (2), pp. e000317-?.  show abstract

Turajlic, S. Swanton, C. Boshoff, C. (2018). Kidney cancer: The next decade. Journal of experimental medicine, Vol.215 (10), pp. 2477-2479.  show abstract

Flynn, M. Pickering, L. Larkin, J. Turajlic, S. (2018). Immune-checkpoint inhibitors in melanoma and kidney cancer: from sequencing to rational selection. Therapeutic advances in medical oncology, Vol.10, pp. 1758835918777427-?.  show abstract

Arce Vargas, F. Furness, A.J. Litchfield, K. Joshi, K. Rosenthal, R. Ghorani, E. Solomon, I. Lesko, M.H. Ruef, N. Roddie, C. Henry, J.Y. Spain, L. Ben Aissa, A. Georgiou, A. Wong, Y.N. Smith, M. Strauss, D. Hayes, A. Nicol, D. O'Brien, T. Mårtensson, L. Ljungars, A. Teige, I. Frendéus, B. TRACERx Melanoma, TRACERx Renal, TRACERx Lung consortia, Pule, M. Marafioti, T. Gore, M. Larkin, J. Turajlic, S. Swanton, C. Peggs, K.S. Quezada, S.A. (2018). Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies. Cancer cell, Vol.33 (4), pp. 649-663.e4.  show abstract

Mitchell, T.J. Turajlic, S. Rowan, A. Nicol, D. Farmery, J.H. O’Brien, T. Martincorena, I. Tarpey, P. Angelopoulos, N. Yates, L.R. Butler, A.P. Raine, K. Stewart, G.D. Challacombe, B. Fernando, A. Lopez, J.I. Hazell, S. Chandra, A. Chowdhury, S. Rudman, S. Soultati, A. Stamp, G. Fotiadis, N. Pickering, L. Au, L. Spain, L. Lynch, J. Stares, M. Teague, J. Maura, F. Wedge, D.C. Horswell, S. Chambers, T. Litchfield, K. Xu, H. Stewart, A. Elaidi, R. Oudard, S. McGranahan, N. Csabai, I. Gore, M. Futreal, P.A. Larkin, J. Lynch, A.G. Szallasi, Z. Swanton, C. Campbell, P.J. (2018). Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal. Cell, Vol.173 (3), pp. 611-623.e17.

Tio, M. Rai, R. Ezeoke, O.M. McQuade, J.L. Zimmer, L. Khoo, C. Park, J.J. Spain, L. Turajlic, S. Ardolino, L. Yip, D. Goldinger, S.M. Cohen, J.V. Millward, M. Atkinson, V. Kane, A.Y. Ascierto, P.A. Garbe, C. Gutzmer, R. Johnson, D.B. Rizvi, H.A. Joshua, A.M. Hellmann, M.D. Long, G.V. Menzies, A.M. (2018). Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection. European journal of cancer, Vol.104, pp. 137-144.

Turajlic, S. Xu, H. Litchfield, K. Rowan, A. Horswell, S. Chambers, T. O'Brien, T. Lopez, J.I. Watkins, T.B. Nicol, D. Stares, M. Challacombe, B. Hazell, S. Chandra, A. Mitchell, T.J. Au, L. Eichler-Jonsson, C. Jabbar, F. Soultati, A. Chowdhury, S. Rudman, S. Lynch, J. Fernando, A. Stamp, G. Nye, E. Stewart, A. Xing, W. Smith, J.C. Escudero, M. Huffman, A. Matthews, N. Elgar, G. Phillimore, B. Costa, M. Begum, S. Ward, S. Salm, M. Boeing, S. Fisher, R. Spain, L. Navas, C. Grönroos, E. Hobor, S. Sharma, S. Aurangzeb, I. Lall, S. Polson, A. Varia, M. Horsfield, C. Fotiadis, N. Pickering, L. Schwarz, R.F. Silva, B. Herrero, J. Luscombe, N.M. Jamal-Hanjani, M. Rosenthal, R. Birkbak, N.J. Wilson, G.A. Pipek, O. Ribli, D. Krzystanek, M. Csabai, I. Szallasi, Z. Gore, M. McGranahan, N. Van Loo, P. Campbell, P. Larkin, J. Swanton, C. TRACERx Renal Consortium, (2018). Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal. Cell, Vol.173 (3), pp. 595-610.e11.  show abstract

Turajlic, S. Xu, H. Litchfield, K. Rowan, A. Chambers, T. Lopez, J.I. Nicol, D. O'Brien, T. Larkin, J. Horswell, S. Stares, M. Au, L. Jamal-Hanjani, M. Challacombe, B. Chandra, A. Hazell, S. Eichler-Jonsson, C. Soultati, A. Chowdhury, S. Rudman, S. Lynch, J. Fernando, A. Stamp, G. Nye, E. Jabbar, F. Spain, L. Lall, S. Guarch, R. Falzon, M. Proctor, I. Pickering, L. Gore, M. Watkins, T.B. Ward, S. Stewart, A. DiNatale, R. Becerra, M.F. Reznik, E. Hsieh, J.J. Richmond, T.A. Mayhew, G.F. Hill, S.M. McNally, C.D. Jones, C. Rosenbaum, H. Stanislaw, S. Burgess, D.L. Alexander, N.R. Swanton, C. PEACE, TRACERx Renal Consortium, (2018). Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal. Cell, Vol.173 (3), pp. 581-594.e12.  show abstract

Turajlic, S. Larkin, J. (2018). Immunotherapy for Melanoma Metastatic to the Brain. New england journal of medicine, Vol.379 (8), pp. 789-790.

Spain, L. Walls, G. Messiou, C. Turajlic, S. Gore, M. Larkin, J. (2017). Efficacy and toxicity of rechallenge with combination immune checkpoint blockade in metastatic melanoma: a case series. Cancer immunology, immunotherapy : cii, Vol.66 (1), pp. 113-117.  show abstract

Spain, L. Walls, G. Julve, M. O'Meara, K. Schmid, T. Kalaitzaki, E. Turajlic, S. Gore, M. Rees, J. Larkin, J. (2017). Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literature. Annals of oncology : official journal of the european society for medical oncology, Vol.28 (2), pp. 377-385.  show abstract

Jamal-Hanjani, M. Wilson, G.A. McGranahan, N. Birkbak, N.J. Watkins, T.B. Veeriah, S. Shafi, S. Johnson, D.H. Mitter, R. Rosenthal, R. Salm, M. Horswell, S. Escudero, M. Matthews, N. Rowan, A. Chambers, T. Moore, D.A. Turajlic, S. Xu, H. Lee, S.-. Forster, M.D. Ahmad, T. Hiley, C.T. Abbosh, C. Falzon, M. Borg, E. Marafioti, T. Lawrence, D. Hayward, M. Kolvekar, S. Panagiotopoulos, N. Janes, S.M. Thakrar, R. Ahmed, A. Blackhall, F. Summers, Y. Shah, R. Joseph, L. Quinn, A.M. Crosbie, P.A. Naidu, B. Middleton, G. Langman, G. Trotter, S. Nicolson, M. Remmen, H. Kerr, K. Chetty, M. Gomersall, L. Fennell, D.A. Nakas, A. Rathinam, S. Anand, G. Khan, S. Russell, P. Ezhil, V. Ismail, B. Irvin-Sellers, M. Prakash, V. Lester, J.F. Kornaszewska, M. Attanoos, R. Adams, H. Davies, H. Dentro, S. Taniere, P. O'Sullivan, B. Lowe, H.L. Hartley, J.A. Iles, N. Bell, H. Ngai, Y. Shaw, J.A. Herrero, J. Szallasi, Z. Schwarz, R.F. Stewart, A. Quezada, S.A. Le Quesne, J. Van Loo, P. Dive, C. Hackshaw, A. Swanton, C. TRACERx Consortium, (2017). Tracking the Evolution of Non-Small-Cell Lung Cancer. The new england journal of medicine, Vol.376 (22), pp. 2109-2121.  show abstract

Turajlic, S. Swanton, C. (2017). Implications of cancer evolution for drug development. Nature reviews. drug discovery, Vol.16 (7), pp. 441-442.

Turajlic, S. Litchfield, K. Xu, H. Rosenthal, R. McGranahan, N. Reading, J.L. Wong, Y.N. Rowan, A. Kanu, N. Al Bakir, M. Chambers, T. Salgado, R. Savas, P. Loi, S. Birkbak, N.J. Sansregret, L. Gore, M. Larkin, J. Quezada, S.A. Swanton, C. (2017). Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis. The lancet. oncology, Vol.18 (8), pp. 1009-1021.  show abstract

Litchfield, K. Turajlic, S. Swanton, C. (2017). The GENIE Is Out of the Bottle: Landmark Cancer Genomics Dataset Released. Cancer discovery, Vol.7 (8), pp. 796-798.  show abstract

(2017). TRACERx Renal: tracking renal cancer evolution through therapy. Nature reviews urology, Vol.14 (10), pp. 575-576.

Arce Vargas, F. Furness, A.J. Solomon, I. Joshi, K. Mekkaoui, L. Lesko, M.H. Miranda Rota, E. Dahan, R. Georgiou, A. Sledzinska, A. Ben Aissa, A. Franz, D. Werner Sunderland, M. Wong, Y.N. Henry, J.Y. O'Brien, T. Nicol, D. Challacombe, B. Beers, S.A. Melanoma TRACERx Consortium, Renal TRACERx Consortium, Lung TRACERx Consortium, Turajlic, S. Gore, M. Larkin, J. Swanton, C. Chester, K.A. Pule, M. Ravetch, J.V. Marafioti, T. Peggs, K.S. Quezada, S.A. (2017). Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors. Immunity, Vol.46 (4), pp. 577-586.  show abstract

McGranahan, N. Rosenthal, R. Hiley, C.T. Rowan, A.J. Watkins, T.B. Wilson, G.A. Birkbak, N.J. Veeriah, S. Van Loo, P. Herrero, J. Swanton, C. Swanton, C. Jamal-Hanjani, M. Veeriah, S. Shafi, S. Czyzewska-Khan, J. Johnson, D. Laycock, J. Bosshard-Carter, L. Rosenthal, R. Gorman, P. Hynds, R.E. Wilson, G. Birkbak, N.J. Watkins, T.B. McGranahan, N. Horswell, S. Mitter, R. Escudero, M. Stewart, A. Van Loo, P. Rowan, A. Xu, H. Turajlic, S. Hiley, C. Abbosh, C. Goldman, J. Stone, R.K. Denner, T. Matthews, N. Elgar, G. Ward, S. Costa, M. Begum, S. Phillimore, B. Chambers, T. Nye, E. Graca, S. Al Bakir, M. Joshi, K. Furness, A. Ben Aissa, A. Wong, Y.N. Georgiou, A. Quezada, S. Hartley, J.A. Lowe, H.L. Herrero, J. Lawrence, D. Hayward, M. Panagiotopoulos, N. Kolvekar, S. Falzon, M. Borg, E. Marafioti, T. Simeon, C. Hector, G. Smith, A. Aranda, M. Novelli, M. Oukrif, D. Janes, S.M. Thakrar, R. Forster, M. Ahmad, T. Lee, S.M. Papadatos-Pastos, D. Carnell, D. Mendes, R. George, J. Navani, N. Ahmed, A. Taylor, M. Choudhary, J. Summers, Y. Califano, R. Taylor, P. Shah, R. Krysiak, P. Rammohan, K. Fontaine, E. Booton, R. Evison, M. Crosbie, P. Moss, S. Idries, F. Joseph, L. Bishop, P. Chaturved, A. Quinn, A.M. Doran, H. Leek, A. Harrison, P. Moore, K. Waddington, R. Novasio, J. Blackhall, F. Rogan, J. Smith, E. Dive, C. Tugwood, J. Brady, G. Rothwell, D.G. Chemi, F. Pierce, J. Gulati, S. Naidu, B. Langman, G. Trotter, S. Bellamy, M. Bancroft, H. Kerr, A. Kadiri, S. Webb, J. Middleton, G. Djearaman, M. Fennell, D. Shaw, J.A. Le Quesne, J. Moore, D. Nakas, A. Rathinam, S. Monteiro, W. Marshall, H. Nelson, L. Bennett, J. Riley, J. Primrose, L. Martinson, L. Anand, G. Khan, S. Amadi, A. Nicolson, M. Kerr, K. Palmer, S. Remmen, H. Miller, J. Buchan, K. Chetty, M. Gomersall, L. Lester, J. Edwards, A. Morgan, F. Adams, H. Davies, H. Kornaszewska, M. Attanoos, R. Lock, S. Verjee, A. MacKenzie, M. Wilcox, M. Bell, H. Hackshaw, A. Ngai, Y. Smith, S. Gower, N. Ottensmeier, C. Chee, S. Johnson, B. Alzetani, A. Shaw, E. Lim, E. De Sousa, P. Barbosa, M.T. Bowman, A. Jordan, S. Rice, A. Raubenheimer, H. Proli, C. Cufari, M.E. Ronquillo, J.C. Kwayie, A. Bhayani, H. Hamilton, M. Bakar, Y. Mensah, N. Ambrose, L. Devaraj, A. Buderi, S. Finch, J. Azcarate, L. Chavan, H. Green, S. Mashinga, H. Nicholson, A.G. Lau, K. Sheaff, M. Schmid, P. Conibear, J. Ezhil, V. Ismail, B. Irvin-sellers, M. Prakash, V. Russell, P. Light, T. Horey, T. Danson, S. Bury, J. Edwards, J. Hill, J. Matthews, S. Kitsanta, Y. Suvarna, K. Fisher, P. Keerio, A.D. Shackcloth, M. Gosney, J. Postmus, P. Feeney, S. Asante-Siaw, J. Aerts, H.J. Dentro, S. Dessimoz, C. (2017). Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution. Cell, Vol.171 (6), pp. 1259-1271.e11.

Abbosh, C. Birkbak, N.J. Wilson, G.A. Jamal-Hanjani, M. Constantin, T. Salari, R. Le Quesne, J. Moore, D.A. Veeriah, S. Rosenthal, R. Marafioti, T. Kirkizlar, E. Watkins, T.B. McGranahan, N. Ward, S. Martinson, L. Riley, J. Fraioli, F. Al Bakir, M. Grönroos, E. Zambrana, F. Endozo, R. Bi, W.L. Fennessy, F.M. Sponer, N. Johnson, D. Laycock, J. Shafi, S. Czyzewska-Khan, J. Rowan, A. Chambers, T. Matthews, N. Turajlic, S. Hiley, C. Lee, S.M. Forster, M.D. Ahmad, T. Falzon, M. Borg, E. Lawrence, D. Hayward, M. Kolvekar, S. Panagiotopoulos, N. Janes, S.M. Thakrar, R. Ahmed, A. Blackhall, F. Summers, Y. Hafez, D. Naik, A. Ganguly, A. Kareht, S. Shah, R. Joseph, L. Marie Quinn, A. Crosbie, P.A. Naidu, B. Middleton, G. Langman, G. Trotter, S. Nicolson, M. Remmen, H. Kerr, K. Chetty, M. Gomersall, L. Fennell, D.A. Nakas, A. Rathinam, S. Anand, G. Khan, S. Russell, P. Ezhil, V. Ismail, B. Irvin-Sellers, M. Prakash, V. Lester, J.F. Kornaszewska, M. Attanoos, R. Adams, H. Davies, H. Oukrif, D. Akarca, A.U. Hartley, J.A. Lowe, H.L. Lock, S. Iles, N. Bell, H. Ngai, Y. Elgar, G. Szallasi, Z. Schwarz, R.F. Herrero, J. Stewart, A. Quezada, S.A. Peggs, K.S. Van Loo, P. Dive, C. Lin, C.J. Rabinowitz, M. Aerts, H.J. Hackshaw, A. Shaw, J.A. Zimmermann, B.G. Swanton, C. (2017). Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature, Vol.545 (7655), pp. 446-451.

Spain, L. Higgins, R. Gopalakrishnan, K. Turajlic, S. Gore, M. Larkin, J. (2016). Acute renal allograft rejection after immune checkpoint inhibitor therapy for metastatic melanoma. Annals of oncology, Vol.27 (6), pp. 1135-1137.

Turajlic, S. Swanton, C. (2016). Metastasis as an evolutionary process. Science, Vol.352 (6282), pp. 169-175.  show abstract

Turajlic, S. Larkin, J. (2016). Systemic treatment of advanced papillary renal cell carcinoma: Where next?. European journal of cancer (oxford, england : 1990), Vol.69, pp. 223-225.

Turajlic, S. McGranahan, N. Swanton, C. (2015). Inferring mutational timing and reconstructing tumour evolutionary histories. Biochimica et biophysica acta (bba) - reviews on cancer, Vol.1855 (2), pp. 264-275.

Gulati, S. Turajlic, S. Larkin, J. Bates, P.A. Swanton, C. (2015). Relapse models for clear cell renal carcinoma. The lancet oncology, Vol.16 (8), pp. e376-e378.

Soultati, A. Stares, M. Swanton, C. Larkin, J. Turajlic, S. (2015). How should clinicians address intratumour heterogeneity in clear cell renal cell carcinoma?. Current opinion in urology, Vol.25 (5), pp. 358-366.

Turajlic, S. Larkin, J. Swanton, C. (2015). Academically led clinical trials: challenges and opportunities. Annals of oncology, Vol.26 (10), pp. 2010-2011.

Turajlic, S. Swanton, C. (2015). Tracking tumour evolution through liquid biopsy. Nature reviews clinical oncology, Vol.12 (10), pp. 565-566.

Turajlic, S. Larkin, J. Swanton, C. (2015). SnapShot: Renal Cell Carcinoma. Cell, Vol.163 (6), pp. 1556-1556.e1.

Turajlic, S. Furney, S.J. Stamp, G. Rana, S. Ricken, G. Oduko, Y. Saturno, G. Springer, C. Hayes, A. Gore, M. Larkin, J. Marais, R. (2014). Whole-genome sequencing reveals complex mechanisms of intrinsic resistance to BRAF inhibition. Annals of oncology, Vol.25 (5), pp. 959-967.

Furney, S.J. Turajlic, S. Stamp, G. Thomas, J.M. Hayes, A. Strauss, D. Gavrielides, M. Xing, W. Gore, M. Larkin, J. Marais, R. (2014). The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis. Pigment cell & melanoma research, Vol.27 (5), pp. 835-838.

Sanchez-Laorden, B. Viros, A. Girotti, M.R. Pedersen, M. Saturno, G. Zambon, A. Niculescu-Duvaz, D. Turajlic, S. Hayes, A. Gore, M. Larkin, J. Lorigan, P. Cook, M. Springer, C. Marais, R. (2014). BRAF Inhibitors Induce Metastasis in RAS Mutant or Inhibitor-Resistant Melanoma Cells by Reactivating MEK and ERK Signaling. Science signaling, Vol.7 (318).  show abstract

Girotti, M.R. Pedersen, M. Sanchez-Laorden, B. Viros, A. Turajlic, S. Niculescu-Duvaz, D. Zambon, A. Sinclair, J. Hayes, A. Gore, M. Lorigan, P. Springer, C. Larkin, J. Jorgensen, C. Marais, R. (2013). Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma. Cancer discovery, Vol.3 (2), pp. 158-167.  show abstract

Furney, S.J. Pedersen, M. Gentien, D. Dumont, A.G. Rapinat, A. Desjardins, L. Turajlic, S. Piperno-Neumann, S. de la Grange, P. Roman-Roman, S. Stern, M.-. Marais, R. (2013). SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma. Cancer discovery, Vol.3 (10), pp. 1122-1129.  show abstract

Khattak, M. Fisher, R. Turajlic, S. Larkin, J. (2013). Targeted therapy and immunotherapy in advanced melanoma: an evolving paradigm. Therapeutic advances in medical oncology, Vol.5 (2), pp. 105-118.  show abstract

Furney, S.J. Turajlic, S. Stamp, G. Nohadani, M. Carlisle, A. Thomas, J.M. Hayes, A. Strauss, D. Gore, M. van den Oord, J. Larkin, J. Marais, R. (2013). Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma. The journal of pathology, Vol.230 (3), pp. 261-269.

Turajlic, S. Ali, Z. Yousaf, N. Larkin, J. (2013). Phase I/II RAF kinase inhibitors in cancer therapy. Expert opinion on investigational drugs, Vol.22 (6), pp. 739-749.

Turajlic, S. Furney, S.J. Lambros, M.B. Mitsopoulos, C. Kozarewa, I. Geyer, F.C. MacKay, A. Hakas, J. Zvelebil, M. Lord, C.J. Ashworth, A. Thomas, M. Stamp, G. Larkin, J. Reis-Filho, J.S. Marais, R. (2012). Whole genome sequencing of matched primary and metastatic acral melanomas. Genome research, Vol.22 (2), pp. 196-207.  show abstract

Natrajan, R. Mackay, A. Lambros, M.B. Weigelt, B. Wilkerson, P.M. Manie, E. Grigoriadis, A. A'Hern, R. van der Groep, P. Kozarewa, I. Popova, T. Mariani, O. Turajlic, S. Furney, S.J. Marais, R. Rodruigues, D.-. Flora, A.C. Wai, P. Pawar, V. McDade, S. Carroll, J. Stoppa-Lyonnet, D. Green, A.R. Ellis, I.O. Swanton, C. van Diest, P. Delattre, O. Lord, C.J. Foulkes, W.D. Vincent-Salomon, A. Ashworth, A. Stern, M.H. Reis-Filho, J.S. (2012). A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancers. The journal of pathology, Vol.227 (1), pp. 29-41.

Furney, S.J. Turajlic, S. Fenwick, K. Lambros, M.B. MacKay, A. Ricken, G. Mitsopoulos, C. Kozarewa, I. Hakas, J. Zvelebil, M. Lord, C.J. Ashworth, A. Reis-Filho, J.S. Herlyn, M. Murata, H. Marais, R. (2012). Genomic characterisation of acral melanoma cell lines. Pigment cell & melanoma research, Vol.25 (4), pp. 488-492.

Larkin, J.M. Turajlic, S. Nathan, P.D. Lorigan, P. Stamp, G. Gonzalez de Castro, D. Martin, N. Griffiths, J. Edmonds, K. Sarker, S. James, M.G. A'Hern, R. Coombes, G. Snowdon, C. Bliss, J.M. Gore, M.E. Marais, R. (2011). A phase II trial of nilotinib in the treatment of patients with KIT mutated advanced acral and mucosal melanoma (NICAM). J clin oncol, Vol.29 (15_suppl), p. TPS229.  show abstract

Perez, A. Turajlic, S. Szyszko, T. O'Doherty, M. Calonje, E. Harries, M. Acland, K. (2010). Generalized melanosis and melanuria in a patient with metastatic melanoma. Clinical and experimental dermatology, Vol.35 (3), pp. e37-e39.

Ferronika, P. Hof, J. Kats-Ugurlu, G. Sijmons, R.H. Terpstra, M.M. de Lange, K. Leliveld-Kors, A. Westers, H. Kok, K. Comprehensive Profiling of Primary and Metastatic ccRCC Reveals a High Homology of the Metastases to a Subregion of the Primary Tumour. Cancers, Vol.11 (6), pp. 812-812.  show abstract

Gudd, C.L. Au, L. Triantafyllou, E. Shum, B. Liu, T. Nathwani, R. Kumar, N. Mukherjee, S. Dhar, A. Woollard, K.J. Yone, Y. Pinato, D.J. Thursz, M.R. Goldin, R.D. Gore, M.E. Larkin, J. Khamri, W. Antoniades, C.G. Turajlic, S. Possamai, L.A. Activation and transcriptional profile of monocytes and CD8+ T cells are altered in checkpoint inhibitor-related hepatitis. Journal of hepatology, Vol.75 (1), pp. 177-189.  show abstract

Carbone, F. Huang, J.K. Perelli, L. Poggetto, E.D. Gutschner, T. Tomihara, H. Soeung, M. Lam, T.N. Xia, R. Zhu, C. Song, X. Zhang, J. Sircar, K. Malouf, G.G. Sgambato, A. Karam, J.A. Gao, J. Jonasch, E. Viale, A. Draetta, G.F. Futreal, A. Bakouny, Z. Van Allen, E.M. Choueiri, T. Msaouel, P. Litchfield, K. Turajlic, S. Heffernan, T.P. Chen, Y.B. DiNatale, R.G. Hakimi, A.A. Bristow, C.A. Tannir, N.M. Carugo, A. Genovese, G. 9p21 Loss Defines the Evolutionary Patterns of Aggressive Renal Cell Carcinomas. , .  show abstract

Hodzic, E. Shrestha, R. Malikic, S. Collins, C.C. Litchfield, K. Turajlic, S. Sahinalp, S.C. Identification of Conserved Evolutionary Trajectories in Tumors. , .  show abstract

Zhao, Y. Fu, X. Lopez, J. Rowan, A. Au, L. Fendler, A. Hazell, S. Xu, H. Horswell, S. Shephard, S. Spain, L. Byrne, F. Stamp, G. O'Brien, T. Nicol, D. Augustine, M. Chandra, A. Rudman, S. Toncheva, A. Pickering, L. Larkin, J. Sahai, E. Bates, P. Swanton, C. Turajlic, S. Litchfield, K. Selection of metastasis competent subclones in the tumour interior: TRACERx renal. , .  show abstract

Fu, X. Zhao, Y. Lopez, J. Rowan, A. Au, L. Fendler, A. Hazell, S. Xu, H. Horswell, S. Shepherd, S. Spain, L. Byrne, F. Stamp, G. O'Brien, T. Nicol, D. Augustine, M. Chandra, A. Rudman, S. Toncheva, A. Furness, A. Pickering, L. Orton, M. Doran, S. Koh, D.-. Messiou, C. Dafydd, D.A. Kumar, S. Larkin, J. Swanton, C. Sahai, E. Litchfield, K. Turajlic, S. Bates, P. Spatial patterns of tumour growth impact clonal diversification: computational modelling and evidence in the TRACERx Renal study. , .  show abstract

Switzer, B. Haanen, J. Lorigan, P.C. Puzanov, I. Turajlic, S. Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors. Journal for immunotherapy of cancer, Vol.9 (7).  show abstract

Au, L. Hatipoglu, E. Robert de Massy, M. Litchfield, K. Beattie, G. Rowan, A. Schnidrig, D. Thompson, R. Byrne, F. Horswell, S. Fotiadis, N. Hazell, S. Nicol, D. Shepherd, S.T. Fendler, A. Mason, R. Del Rosario, L. Edmonds, K. Lingard, K. Sarker, S. Mangwende, M. Carlyle, E. Attig, J. Joshi, K. Uddin, I. Becker, P.D. Sunderland, M.W. Akarca, A. Puccio, I. Yang, W.W. Lund, T. Dhillon, K. Vasquez, M.D. Ghorani, E. Xu, H. Spencer, C. López, J.I. Green, A. Mahadeva, U. Borg, E. Mitchison, M. Moore, D.A. Proctor, I. Falzon, M. Pickering, L. Furness, A.J. Reading, J.L. Salgado, R. Marafioti, T. Jamal-Hanjani, M. PEACE Consortium, Kassiotis, G. Chain, B. Larkin, J. Swanton, C. Quezada, S.A. Turajlic, S. TRACERx Renal Consortium, Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma. Cancer cell, Vol.39 (11), pp. 1497-1518.e11.  show abstract

Fu, X. Zhao, Y. Lopez, J.I. Rowan, A. Au, L. Fendler, A. Hazell, S. Xu, H. Horswell, S. Shepherd, S.T. Spencer, C.E. Spain, L. Byrne, F. Stamp, G. O'Brien, T. Nicol, D. Augustine, M. Chandra, A. Rudman, S. Toncheva, A. Furness, A.J. Pickering, L. Kumar, S. Koh, D.-. Messiou, C. Dafydd, D.A. Orton, M.R. Doran, S.J. Larkin, J. Swanton, C. Sahai, E. Litchfield, K. Turajlic, S. TRACERx Renal Consortium, Bates, P.A. Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study. Nature ecology & evolution, Vol.6 (1), pp. 88-102.  show abstract

Alexander, J.L. Ibraheim, H. Sheth, B. Little, J. Khan, M.S. Richards, C. Hunter, N. Chauhan, D. Ratnakumaran, R. McHugh, K. Pinato, D.J. Nathan, P. Choy, J. Crusz, S.M. Furness, A. Turajlic, S. Pickering, L. Larkin, J. Teare, J.P. Papa, S. Speight, A. Sharma, A. Powell, N. Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab. Journal for immunotherapy of cancer, Vol.9 (7).  show abstract

Buck, M.D. Poirier, E.Z. Cardoso, A. Frederico, B. Canton, J. Barrell, S. Beale, R. Byrne, R. Caidan, S. Crawford, M. Cubitt, L. Gandhi, S. Goldstone, R. Grant, P.R. Gulati, K. Hindmarsh, S. Howell, M. Hubank, M. Instrell, R. Jiang, M. Kassiotis, G. Lu, W.-. MacRae, J.I. Martini, I. Miller, D. Moore, D. Nastouli, E. Nicod, J. Nightingale, L. Olsen, J. Oomatia, A. O'Reilly, N. Rideg, A. Song, O.-. Strange, A. Swanton, C. Turajlic, S. Wu, M. Reis e Sousa, C. SARS-CoV-2 detection by a clinical diagnostic RT-LAMP assay. Wellcome open research, Vol.6, pp. 9-9.  show abstract

Litchfield, D.K. Stanislaw, S. Spain, L. Gallegos, L. Rowan, A. Schnidrig, D. Rosenbaum, H. Harle, A. Au, L. Hill, S. Tippu, Z. Thomas, J. Xu, H. Horswell, S. Barhoumi, A. Jones, C. Leith, K.F. Burgess, D.L. Watkins, T.B. Lim, E. Birkbak, N.J. Lamy, P. Nordentoft, I. Dyrskjøt, L. Hazell, S. Jamal-Hanjani, M. Larkin, J. Swanton, C. Alexander, N.R. Turajlic, S. Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue. Ssrn electronic journal, .

Fendler, A. Au, L. Shepherd, S.T. Byrne, F. Cerrone, M. Boos, L.A. Rzeniewicz, K. Gordon, W. Shum, B. Gerard, C.L. Ward, B. Xie, W. Schmitt, A.M. Joharatnam-Hogan, N. Cornish, G.H. Pule, M. Mekkaoui, L. Ng, K.W. Carlyle, E. Edmonds, K. Rosario, L.D. Sarker, S. Lingard, K. Mangwende, M. Holt, L. Ahmod, H. Stone, R. Gomes, C. Flynn, H.R. Agua-Doce, A. Hobson, P. Caidan, S. Howell, M. Wu, M. Goldstone, R. Crawford, M. Cubitt, L. Patel, H. Gavrielides, M. Nye, E. Snijders, A.P. MacRae, J.I. Nicod, J. Gronthoud, F. Shea, R.L. Messiou, C. Cunningham, D. Chau, I. Starling, N. Turner, N. Welsh, L. van As, N. Jones, R.L. Droney, J. Banerjee, S. Tatham, K.C. Jhanji, S. O’Brien, M. Curtis, O. Harrington, K. Bhide, S. Bazin, J. Robinson, A. Stephenson, C. Slattery, T. Khan, Y. Tippu, Z. Leslie, I. Gennatas, S. Okines, A. Reid, A. Young, K. Furness, A.J. Pickering, L. Gandhi, S. Gamblin, S. Swanton, C. Nicholson, E. Kumar, S. Yousaf, N. Wilkinson, K.A. Swerdlow, A. Harvey, R. Kassiotis, G. Larkin, J. Wilkinson, R.J. Turajlic, S. Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study. Nature cancer, Vol.2 (12), pp. 1321-1337.  show abstract


Conferences

Fendler, A.Boos, L.Au, L.Shepherd, S.Byrne, F.Edmonds, K.Carlyle, E.Rosario, L.D.Shum, B.Larkin, J.Pickering, L.Furness, A.Turajlic, S. (2020). Abstract PO-091: CAPTURE: Cancer and COVID-19 antiviral immune monitoring study, Clinical Cancer Research, Vol.26 (18_Supplement).

Girotti, M.R.Pedersen, M.Sanchez-Laorden, B.Viros, A.Turajlic, S.Niculescu-Duvaz, D.Zambon, A.Sinclair, J.Hayes, A.Gore, M.Springer, C.Larkin, J.Jorgensen, C.Marais, R. (2013). Abstract 3404: Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma., Presented at Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC, Experimental and Molecular Therapeutics, .

Larkin, J.M.Turajlic, S.Nathan, P.D.Lorigan, P.Stamp, G.Gonzalez de Castro, D.Martin, N.Griffiths, J.Edmonds, K.Sarker, S.James, M.G.A'Hern, R.Coombes, G.Snowdon, C.Bliss, J.M.Gore, M.E.Marais, R. (2011). A phase II trial of nilotinib in the treatment of patients with KIT mutated advanced acral and mucosal melanoma (NICAM)., Journal of Clinical Oncology, Vol.29 (15_suppl), p.TPS229.

In this section

Research overview Research projects Publications